BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3901535)

  • 1. [Absence of effect of secretin and cholecystokinin on plasma concentrations of vasoactive intestinal polypeptide and pancreatic glucagon].
    Bauer FE; Schulz E; Janisch HD; von Kleist D; Hampel KE
    Wien Klin Wochenschr; 1985 Jul; 97(14):603-5. PubMed ID: 3901535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Secretin and cholecystokinin: hormonal action on the concentration of vasoactive intestinal polypeptide and gastrin in human subjects?].
    Bauer FE; Schulz E; von Kleist D; Janisch HD; Hampel KE
    Z Gastroenterol; 1984 Aug; 22(8):388-93. PubMed ID: 6485438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of pancreatic endocrine function by cholecystokinin: studies with MK-329, a nonpeptide cholecystokinin receptor antagonist.
    Liddle RA; Gertz BJ; Kanayama S; Beccaria L; Gettys TW; Taylor IL; Rushakoff RJ; Williams VC; Coker LD
    J Clin Endocrinol Metab; 1990 May; 70(5):1312-8. PubMed ID: 2186058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of human pancreatic polypeptide and gastrin by Boots and GIH secretin: in vitro and in vivo studies.
    Meryn S; Bauman WA; Panzer S; Straus E
    Int J Clin Pharmacol Ther Toxicol; 1987 Jan; 25(1):1-6. PubMed ID: 3557722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressive effect of secretin upon pancreatic alpha cell function.
    Santeusanio F; Faloona GR; Unger RH
    J Clin Invest; 1972 Jul; 51(7):1743-9. PubMed ID: 4555784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of cholecystokinin, vasoactive intestinal peptide and secretin on pancreatic and biliary secretion in laying hens.
    Duke GE; Larntz K; Hunt H
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1987; 86(1):97-102. PubMed ID: 2881734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of synthetic secretin and GIH-cholecystokinin on serum gastrin levels].
    Bauer FE; von Kleist D; Schulz E; Janisch HD; Hampel KE
    Wien Med Wochenschr; 1984 Aug; 134(15-16):351-4. PubMed ID: 6495747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of cholecystokinin, vasoactive intestinal peptide and secretin on plasma concentration of avian pancreatic polypeptide in laying hens.
    Duke GE; Kimmel JR; Hunt H; Pollock HG; Mosher JA
    Comp Biochem Physiol A Comp Physiol; 1986; 85(2):347-50. PubMed ID: 2876840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in the blood gas concentration caused by secretin and cholecystokinin. Indication of a vasomotor effect?
    Bauer FE; von Kleist D; Janisch HD; Hampel KE
    J Clin Gastroenterol; 1986 Jun; 8(3 Pt 1):263-6. PubMed ID: 3016071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of secretin, glucagon and VIP on gallbladder contraction.
    Vagne M; Troitskaja V
    Digestion; 1976; 14(1):62-7. PubMed ID: 955325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucagon inhibition of secretin and combined secretin and cholecystokinin stimulated pancreatic exocrine secretion in health and disease.
    Clain JE; Barbezat GO; Waterworth MM; Bank S
    Digestion; 1978; 17(1):11-7. PubMed ID: 627317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of 1-(5-oxohexyl-)3.7-dimethylxanthine (BL 191) on the endocrine and exocrine pancreatic function in man during and following secretin and cholecystokinin-pancreozymin stimulation.
    Dollinger HC; Raptis S; Grebe B; Goebell H; Müller R; Hinze HJ; Pfeiffer EF
    Res Exp Med (Berl); 1973 Nov; 161(4):327-34. PubMed ID: 4358570
    [No Abstract]   [Full Text] [Related]  

  • 13. Potentiating effect of secretin on cholecystokinin-stimulated pancreatic secretion in dogs.
    Chey WY; Lee KY; Chang TM; Chen YF; Millikan L
    Am J Physiol; 1984 Mar; 246(3 Pt 1):G248-52. PubMed ID: 6322594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of chronic pentagastrin, cholecystokinin, and secretin on pancreas of rats.
    Petersen H; Solomon T; Grossman MI
    Am J Physiol; 1978 Mar; 234(3):E286-93. PubMed ID: 343601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The endocrine regulation of exocrine pancreas in preruminant milk-fed calves.
    Davicco MJ; Lefaivre J; Barlet JP
    Ann Rech Vet; 1980; 11(2):123-32. PubMed ID: 6109515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defect in pancreatic exocrine and endocrine response to CCK in genetically diabetic OLETF rats.
    Tachibana I; Akiyama T; Kanagawa K; Shiohara H; Furumi K; Watanabe N; Otsuki M
    Am J Physiol; 1996 Apr; 270(4 Pt 1):G730-7. PubMed ID: 8928805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholecystokinin stimulates growth of human pancreatic adenocarcinoma SW-1990.
    Smith JP; Solomon TE; Bagheri S; Kramer S
    Dig Dis Sci; 1990 Nov; 35(11):1377-84. PubMed ID: 2226098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretin potentiates cholinergically induced glucagon secretion in the mouse.
    Ahrén B; Lundquist I
    Acta Physiol Scand; 1986 Dec; 128(4):575-8. PubMed ID: 3811983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic pancreatitis and diabetes mellitus: plasma and gastroduodenal mucosal profiles of regulatory peptides (gastrin, motilin, secretin, cholecystokinin, gastric inhibitory polypeptide, somatostatin, VIP, substance P, pancreatic polypeptide, glucagon, enteroglucagon, neurotensin).
    Domschke S; Bloom SR; Adrian TE; Lux G; Domschke W
    Hepatogastroenterology; 1988 Oct; 35(5):229-37. PubMed ID: 2465985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholecystokinin downregulates receptors for vasoactive intestinal peptide and secretin in rat pancreatic acini.
    Katsushima S; Adachi H; Honda T; Sato S; Kusui T; Onishi S; Aoki E; Noguchi M; Konishi J
    Am J Physiol; 1990 Mar; 258(3 Pt 1):G395-403. PubMed ID: 2156442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.